This finding points out that B-ALL patients with high cortactin and HS1 expression at diagnosis showed low frequency of complete remission after induction chemotherapy as compared to those express high expression (P<0.01 for both) (Table 3). Here, CTTN is linked to acute lymphoblastic leukemia.